Amyloid-β Production Via Cleavage of Amyloid-β Protein Precursor is Modulated by Cell Density

Journal of Alzheimer's Disease

Volumn 22, Issue 2, 2010, Pages 683-694

  Zhang, Can ^a   Browne, Andrew ^a   Divito, Jason R ^a   Stevenson, Jesse A ^a   Romano, Donna ^a   Dong, Yuanlin ^a   Xie, Zhongcong ^a   Tanzi, Rudolph E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; amyloid ; amyloid protein precursor; cell density

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL DENSITY; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NERVE CELL CULTURE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN PROCESSING; WESTERN BLOTTING;

EID: 78650819421     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100816     Document Type: Article

References (30)

1. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9, 768-778.
2. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555.
3. Tanzi RE, Gusella JF, Watkins PC, Brans GA, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884.
4. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
5. Gandy S (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 115, 1121-1129.
6. Zhang C, Saunders AJ (2007) Therapeutic targeting of the alpha-secretase pathway to treat Alzheimer's disease. Discov Med 7, 113-117.
7. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
8. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
9. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution of gamma-secretase activity. Nat Cell Biol 5, 486-488.
10. Sisodia SS, St George-Hyslop PH (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the prese-nilins fit in? Nat Rev Neurosci 3, 281-290.
11. Xie Z, Dong Y, Maeda U, Xia W, Tanzi RE (2007) RNA interference silencing ofthe adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation. J Biol Chem 282, 4318-4325.
12. Xie Z, Romano DM, Tanzi RE (2005) RNA interference-mediated silencing of X11alpha and X11beta attenuates amyloid beta-protein levels via differential effects on beta-amyloid precursor protein processing. J Biol Chem 280, 15413-15421.
13. Zhang C, Browne A, Child D, Divito JR, Stevenson JA, Tanzi RE Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein. J Biol Chem 285, 8515-8526.
14. Zhang C, Browne A, Child D, Tanzi RE (2010) Curcumin decreases amyloid beta-peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 285, 28472-28480.
15. Huttunen HJ, Guenette SY, Peach C, Greco C, Xia W, Kim DY, Barren C, Tanzi RE, Kovacs DM (2007) HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endo-plasmic reticulum-associated degradation. J Biol Chem 282, 28285-28295.
16. Zhang C, Khandelwal PJ, Chakraborty R, Cuellar TL, Sarangi S, Patel SA, Cosentino CP, O'Connor M, Lee JC, Tanzi RE, Saunders AJ (2007) An AICD-based Functional Screen to Identify APP Metabolism Regulators. Mol Neurodegener 2, 15.
17. Hiltunen M, Lu A, Thomas AV, Romano DM, Kim M, Jones PB, Xie Z, Kounnas MZ, Wagner SL, Berezovska O, Hyman BT, Tesco G, Bertram L, Tanzi RE (2006) Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion. J Biol Chem 281, 32240-32253.
18. Zhang C, Browne A, Kim DY, Tanzi RE (2010) Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage. Curr Alzheimer Res 7, 21-26.
19. Parsons RB, Price GC, Farrant JK, Subramaniam D, Adeagbo-Sheikh J, Austen BM (2006) Statins inhibit the dimerization of beta-secretase via both isoprenoid-and cholesterol-mediated mechanisms. Biochem J 399, 205-214.
20. Xia W, Zhang J, Kholodenko D, Citron M, Podlisny MB, Teplow DB, Haass C, Seubert P, Koo EH, Selkoe DJ (1997) Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 272, 7977-7982.
21. Zhang J, Kang DE, Xia W, Okochi M, Mori H, Selkoe DJ, Koo EH (1998) Subcellular distribution and turnover of presenilins in transfected cells. J Biol Chem 273, 12436-12442.
22. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1, 1291-1296.
23. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, Li HC, Schutte M, Gordon R, Holstein GR, Martinelli G, MehtaP, Friedrich VL, Jr., Robakis NK (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 4, 893-902.
24. Kouchi Z, Barthet G, Serban G, Georgakopoulos A, Shioi J, Robakis NK (2009) p120 catenin recruits cadherins to gamma-secretase and inhibits production of Abeta peptide. J Biol Chem 284, 1954-1961.
25. Serban G, Kouchi Z, Baki L, Georgakopoulos A, Litterst CM, Shioi J, Robakis NK (2005) Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. J Biol Chem 280, 36007-36012.
26. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK (2002) Apresenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBOJ 21, 1948-1956.
27. Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E (1997) Cell confluence regulates tyrosine phos-phorylation of adherens junction components in endothelial cells. J Cell Sci 110 (Pt 17), 2065-2077.
28. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14, 1837-1851.
29. De Ferrari GV, Moon RT (2006) The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 25, 7545-7553.
30. Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L, Garcia-Abreu J, Ferreira ST (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem 283, 9359-9368.